Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Clin Immunol. 2021 Jun 16;229:108778. doi: 10.1016/j.clim.2021.108778

Table 1:

SCID Cohort Characteristics

Sex (n=151) 105 male (70%)

Proportion who had newborn screening (n=151) 63 (42%)

Age (years) of survivors (n=136) at time of survey <2 18 (13%)
2 – 5 32 (24%)
5 – 10 31 (23%)
10 – 20 27 (20%)
20 – 30 20 (15%)
30 – 42 8 (6%)

Age (years) of survivors (n=61) at time of survey who had been diagnosed by newborn screening <2 17 (28%)
2 – 5 28 (46%)
5 – 10 15 (24%)
11 1 (2%)

Median age and range (years) of patients with SCID responding for themselves (n=6) 31.5 (range 20 – 42)

Median age and range (years) of patients with SCID for whom a parent or caregiver responded (n=146) 5 (range 0–36)